{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:45:50Z","timestamp":1764402350893},"reference-count":29,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.vaccine.2005.11.012","type":"journal-article","created":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T07:31:18Z","timestamp":1132644678000},"page":"4017-4023","source":"Crossref","is-referenced-by-count":14,"title":["Interchangeability of two diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccines as a fourth dose in 15\u201320-month-old toddlers"],"prefix":"10.1016","volume":"24","author":[{"given":"Scott A.","family":"Halperin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Tapiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Diaz-Mitoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Duval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne M.","family":"Langley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald B.","family":"Elrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne-Marie","family":"Jacquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.11.012_bib1","unstructured":"National Advisory Committee on Immunization (NACI). Interchangeability of diphtheria, tetanus, acellular pertussis, polio, Haemophilus influenzae type B combination vaccines presently approved for use in Canada for children <7 years of age. Can Commun Dis Rep 2005;31(ACS-1):1\u201310."},{"key":"10.1016\/j.vaccine.2005.11.012_bib2","unstructured":"Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1994;43(RR-1):1\u201338."},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2005.11.012_bib3","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/00006454-200111001-00004","article-title":"Interchangeability of vaccines","volume":"20","author":"Feldman","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2005.11.012_bib4","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0264-410X(98)00228-X","article-title":"Serological correlates of immunity to Bordetella pertussis","volume":"16","author":"Hewlett","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.012_bib5","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/00006454-199509000-00012","article-title":"Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age","volume":"14","author":"Halperin","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2005.11.012_bib6","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/S0264-410X(03)00173-7","article-title":"Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine","volume":"21","author":"Halperin","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.012_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s004310050797","article-title":"Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations","volume":"157","author":"Schmitt","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2005.11.012_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1045-1870(03)00033-5","article-title":"Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines","volume":"14","author":"Rennels","year":"2003","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2005.11.012_bib9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1086\/514741","article-title":"Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses","volume":"28","author":"Halperin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2005.11.012_bib10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1086\/314901","article-title":"The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination","volume":"180","author":"Goldblatt","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.11.012_bib11","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.11.012_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group","volume":"334","author":"Greco","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.11.012_bib13","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","article-title":"A search for serologic correlates of immunity to Bordetella pertussis cough illnesses","volume":"16","author":"Cherry","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.012_bib14","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.012_bib15","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199510193331604","article-title":"A placebo-controlled trial of a pertussis-toxoid vaccine","volume":"333","author":"Trollfors","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.11.012_bib16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0264-410X(00)00301-7","article-title":"Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines","volume":"19","author":"Bryan","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.012_bib17","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/00006454-199909000-00025","article-title":"Antibody responses of healthy neonates of two mixed regimens of hepatitis B vaccine","volume":"18","author":"Seto","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2005.11.012_bib18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0264-410X(91)90217-T","article-title":"Evaluation of initiating a hepatitis B vaccination schedule with one vaccine and completing it with another","volume":"9","author":"Bush","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.012_bib19","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1542\/peds.98.5.898","article-title":"Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimen","volume":"98","author":"Bewley","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2005.11.012_bib20","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0264-410X(96)00086-2","article-title":"Study of booster doses of two Haemophilus influenzae type b conjugate vaccines including their interchangeability","volume":"14","author":"Scheifele","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.11.012_bib21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/bmj.312.7034.817","article-title":"Interchangeability of conjugated Haemophilus influenzae type b vaccines during primary immunisation of infants","volume":"312","author":"Goldblatt","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2005.11.012_bib22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.273.11.849","article-title":"Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants","volume":"273","author":"Anderson","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2005.11.012_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3476(95)70546-5","article-title":"Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccines","volume":"126","author":"Greenberg","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2005.11.012_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/000992280304200201","article-title":"Vaccine interchangeability","volume":"42","author":"Greenberg","year":"2003","journal-title":"Clin Pediatr (Phila)"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2005.11.012_bib25","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/00006454-200111001-00002","article-title":"Principles of pediatric combination vaccines and practical issues related to use in clinical practice","volume":"20","author":"Decker","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2005.11.012_bib26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1542\/peds.109.4.666","article-title":"Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy","volume":"109","author":"Greenberg","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2005.11.012_bib27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00006454-200008000-00018","article-title":"Immunogenicity of acellular pertussis vaccines using two vaccines for primary immunization","volume":"19","author":"von K\u00f6nig","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2005.11.012_bib28","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00006454-199909000-00006","article-title":"Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age","volume":"18","author":"Halperin","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2005.11.012_bib29","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1542\/peds.105.1.e11","article-title":"Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children","volume":"105","author":"Pichichero","year":"2000","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05011400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05011400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T10:46:40Z","timestamp":1683283600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05011400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":29,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0264410X05011400"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.11.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}